Available until March 2024 - Online CME Course

Course Directors: Steven L. Moran, M.D.

Microvascular  Surgery Skills Training - 2023

November 10 - 11, 2023 - Encore at Wynn Las Vegas - Las Vegas, Nevada

This course offers Live (in-person) and Livestream (virtual) attendance options

The 2023 Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium provides a multidisciplinary overview on the importance of early diagnosis and treatment considerations, including surgery, radiation, loco-regional approaches, and systemic therapies. Nationally and internationally renowned faculty offer state-of-the-art updates on current treatment options for patients with hepato-pancreatico-biliary cancers. This timely education is delivered through case-based discussions, interactive Q&A, and didactic presentations. Target audience for this activity includes physicians and allied health professionals.

May 2 - 4, 2024 - Conrad Orlando - Orlando, Florida

This course offers Live (in-person) and Livestream (virtual) attendance options.

Employment of Advanced Practice Registered Nurses (NPs) and Physician Assistants (PAs) is projected to increase within surgical practices to offset growing workforce demands. With goals to improve outcomes, surgical professionals must be apprised of the latest advances in treatment and management and understand and implement best practice models to optimize team-based care. This activity is specifically geared toward the educational needs of surgery NPs, PAs, and other healthcare professionals in both private practice and academic settings.

December 1 - 2, 2023 - ASU Health Futures Center - Phoenix, Arizona

This course offers Live (in-person) and Livestream (virtual) attendance options

Esophageal disease is a rapidly developing medical area marked by significant advances in diagnosis, therapy and identification of new diseases. This CME course will take a comprehensive approach to explore these exciting advancements, including high-resolution manometry and impedance monitoring; new techniques in endoscopic detection and treatment of Barrett’s esophagus; and insights into new diseases such as eosinophilic esophagitis.

March 20 - 23, 2024 - JW Marriott Scottsdale Camelback Inn Resort & Spa - Scottsdale, Arizona

This course offers Live (in-person) and Livestream (virtual) attendance options

This course is designed to update physicians, nurse practitioners, physician assistants and other healthcare providers practicing clinical gastroenterology and hepatology about new approaches to the diagnosis and management of gastrointestinal and liver diseases. Faculty present data on multiple topics including general gastroenterology, inflammatory bowel disease, colorectal neoplasia, esophageal diseases, motility, nutrition, pancreaticobiliary disorders, endoscopy and hepatology.

April 11 - 13, 2024 - Hilton North Scottsdale at Cavasson - Scottsdale, Arizona

This course offers Live (in-person) and Livestream (virtual) attendance options.

Mayo Clinic's Tackling Problematic Sinusitis 2024 course is in its eleventh year. The course is taught by world-class Mayo Clinic faculty who are joined by several global experts. This highly-rated and well-attended course is one of the most prestigious CME activities in the field of rhinology. It provides a comprehensive update on tackling problematic chronic sinusitis as well as other difficult-to-manage rhinologic diagnosis. The course also focuses on new data and progress made in the management of chronic rhinosinusitis. Learners can expect a comprehensive curriculum that covers updates and advances in pathophysiology, office-based procedures, medical therapeutics, new biologics, management of problematic epistaxis from hereditary hemorrhagic telangiectasia, management of septal perforations, as well as Sino nasal tumors and CSF leaks. Personalized medical and surgical strategies that help optimize outcomes are discussed. Techniques covered include repair of cerebrospinal fluid leaks and skull base defects, management of sinonasal tumors, septal perforation repair, injection sclerotherapy for hereditary hemorrhagic telangiectasia, as well as primary and revision sinus surgery.